RecruitingNCT07229053

Hospitalisation Duration in Stroke Patients

Evaluation of the Factors Affecting the Length of Hospitalisation of Patients In Stroke Rehabilitation


Sponsor

Ankara Etlik City Hospital

Enrollment

134 participants

Start Date

Sep 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The stage at which functional recovery stops during the rehabilitation programme and which is one of the important determinants of the discharge decision is called "plateau". Although the definition of plateau is not clear, it is assessed with scales valid for a specific patient. Generally, plateau is not a stage in which functional recovery is completely terminated in stroke patients, but a period of pause. Detection of the plateau stage is important in planning the interruption of treatment and discharge of patients who continue inpatient rehabilitation programme. Factors causing plateau should be identified and necessary modifications should be made for effective continuation of the rehabilitation programme.The average length of hospital stay (weeks) of patients hospitalised due to hemiplegia since the opening of Etlik City Hospital will be determined. Patients will be divided into two groups as those hospitalised for shorter and longer than the average length of stay.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

  • Followed by ischaemic or haemorrhagic stroke
  • No more than 2 years have passed since the date of the incident
  • Patients and their carers who are over 18 years of age

Exclusion Criteria3

  • Cognitive or psychological impairment of the patient or carer
  • The patient is discharged voluntarily or transferred to another department without completing the treatment
  • Not volunteering to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07229053


Related Trials